Intron a and Remeron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Intron a (interferon alfa-2b) and Remeron (mirtazapine). Common drug interactions include pain among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Intron a and Remeron. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Intron a?

Intron a has active ingredients of interferon alfa-2b. eHealthMe is studying from 9,320 Intron a users. Check the latest studies of Intron a.

What is Remeron?

Remeron has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 26,475 Remeron users. Check the latest studies of Remeron.

On Aug, 01, 2026

19 people who take Intron a and Remeron together, and have interactions are studied.

What are the common drug interactions of Intron A and Remeron, by gender? *:

female:

Pain
Bone pain
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Injection site erythema (redness at injection site)
Sepsis (a severe blood infection that can lead to organ failure and death)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Blood creatinine increased
Blood urea increased
Chest pain
Decreased appetite

male:

Fatigue (feeling of tiredness)
Diarrhoea
Decreased appetite
Dysgeusia (disorder of the sense of taste)
Weight decreased
Anaemia (lack of blood)
Appetite disorder (abnormal eating habits)
Arthralgia (joint pain)
Blood creatine phosphokinase increased
Blood creatine phosphokinase mb increased

What are the common drug interactions of Intron A and Remeron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Feeling drunk
Pain
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Abnormal behaviour
Blood creatine phosphokinase increased
Blood creatine phosphokinase mb increased
Chest pain
Short-term memory loss

40-49:

Bone pain
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Injection site erythema (redness at injection site)
Nausea (feeling of having an urge to vomit)
Pain
Sepsis (a severe blood infection that can lead to organ failure and death)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Arthralgia (joint pain)
Blood creatinine increased
Blood urea increased

50-59:

Idiopathic thrombocytopenic purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting)
Petechiae (a small red or purple spot caused by bleeding into the skin)
Purpura (purplish discoloration of the skin)
Thrombocytopenia (decrease of platelets in blood)

60+:

Chills (felling of cold)
Fall
Fatigue (feeling of tiredness)
Feeling cold
Malaise (a feeling of general discomfort or uneasiness)
Diarrhoea
Dry mouth
Dry throat
Dyspnoea exertional (breathlessness or shortness of breath)
Headache (pain in head)

What are the existing conditions these people have? *

Malignant Melanoma (skin cancer rises from melancytes): 2 people, 10.53%
Hepatitis C: 2 people, 10.53%
Skin Cancer: 1 person, 5.26%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 5.26%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 5.26%
Muscle Spasms (muscle contraction): 1 person, 5.26%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 5.26%
Constipation: 1 person, 5.26%
Bipolar Disorder (mood disorder): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Intron a and Remeron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously